Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09CIQ
|
|||
| Former ID |
DIB012352
|
|||
| Drug Name |
Cadralazine
|
|||
| Synonyms |
CGP-18684; CGP-22639; DC-826; ISF-2405; ISF-2469
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Hypertension [ICD-11: BA00-BA04; ICD-9: 401] | Approved | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H21N5O3
|
|||
| Canonical SMILES |
CCN(CC(C)O)C1=NN=C(C=C1)NNC(=O)OCC
|
|||
| InChI |
1S/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19)
|
|||
| InChIKey |
QLTVVOATEHFXLT-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 64241-34-5
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:31331
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.